3Petta S, Muratore C, Craxi A. Non - alcoholic fatty liver disease patho- genesis : the present and the future [ J ]. Dig Liver Dis, 2009,41 ( 9 ) : 615 -625.
4Adams LA, Angulo P. Recent concepts in non - alcoholic fatty liver disease[J]. Diabet Med ,2005,22(9) :1129 - 1133.
5Higgins JPT,Ahman DG, Sterne JAC (editors). Chapter 8 : Assessing risk of bias in included studies. In : Higgins JPT, Green S ( editors ). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 ( updated March 2011 ) [ J ]. The Cochrane Collaboration, 2011.
6Available from www. cochrane - handbook, org. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trims : is blinding necessary? [ J ]. Control Clin Trials, 1996,17 ( 1 ) : 1 - 12.
7Higgins JP,Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta - analyses [ J ]. BMJ,2003,327 (7414) :557 - 560.
8Higgins JP, Thompson SG. Quantifying heterogeneity in a Meta -anal- ysis[ J]. Stat Med,2002,21 ( 11 ) : 1539 - 1558.
